Glucotrack Inc
For the period ended Jun 30, 2024. Filed Aug 13, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 13, 2024
GCTK$1.39-32.2%Stored close · as of Oct 29, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statement of Changes in Stockholders’ Equity (Deficit)
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY
(in thousands of US Dollars except share data) (unaudited)
| In thousands of US Dollars (except share data) | ||||||||
|---|---|---|---|---|---|---|---|---|
| Common Stock · Additional · Receipts on account · Accumulated Other · Total Stockholders’ | ||||||||
| Numbers of Shares · Amount · Paid-in Capital · of shares · Comprehensive Income · Accumulated Deficit · Equity (Deficit) | ||||||||
| Balance as of January 1, 2023 | 3,099,982 | $3 | $103,107 | $4 | $17 | $(101,901) | $1,230 | |
| Loss for the period | - | - | - | - | - | (2,462) | (2,462) | |
| Other comprehensive income | - | - | - | - | 11 | - | 11 | |
| Stock-based compensation | - | - | 229 | - | - | 229 | ||
| Deemed dividend resulted from trigger of down round protection feature of certain warrants granted | - | - | 855 | - | - | (855) | - | |
| Issuance of Common Stock and pre-funded warrants upon completion of public offering, net of offering expenses | 1,075,294 | 1 | 8,729 | - | - | - | 8,730 | |
| Issuance of shares as compensation to the board of directors | 2,998 | -(*) - | 9 | (4) | - | - | 5 | |
| Balance as of June 30, 2023 | 4,178,274 | $4 | $112,929 | $ | - | $28 | $(105,218) | $7,743 |
| Balance at April 1, 2023 | 3,100,562 | $3 | $103,168 | $5 | $22 | $(103,187) | $11 | |
| Loss for the period | - | - | - | - | - | (1,176) | (1,176) | |
| Other comprehensive income | - | - | - | - | 6 | - | 6 | |
| Stock-based compensation | - | - | 172 | - | - | - | 172 | |
| Deemed dividend resulted from trigger of down round protection feature of certain warrants granted | - | - | 855 | - | - | (855) | - | |
| Issuance of Common Stock and pre-funded warrants upon completion of public offering, net of offering expenses | 1,075,294 | 1 | 8,729 | - | - | - | 8,730 | |
| Issuance of restricted shares as compensation towards directors | 2,418 | -(*) - | 5 | (5) | - | - | - | |
| Balance as of June 30, 2023 | 4,178,274 | $4 | $112,929 | $ | - | $28 | $(105,218) | $7,743 |
| Balance as of January 1, 2024 | 4,178,274 | $4 | $112,982 | $48 | $16 | $(109,853) | $3,197 | |
| Loss for the period | - | - | - | - | - | (7,416) | (7,416) | |
| Other comprehensive income | - | - | - | - | 6 | - | 6 | |
| Stock-based compensation | - | - | 228 | - | - | - | 228 | |
| Issuance of restricted shares as compensation towards directors | 86,861 | -(*) | 126 | (48) | - | - | 78 | |
| Restricted shares to be issued as compensation towards directors | - | - | - | 50 | - | - | 50 | |
| Issuance of Common Stock upon private placement transaction (Note 3D) | 79,366 | -(*) | 500 | - | - | - | 500 | |
| Issuance of restricted shares as payment for a previous achievement of milestone pursuant to purchase agreement (Note 4B) | 20,000 | -(*) | - | - | - | - | - | |
| Exercise of prefunded warrants into shares (Note 3A) | 395,294 | -(*) | - | - | - | - | - | |
| Exchange of warrants into shares (Note 3B) | 718,641 | 1 | (1) | - | - | - | - | |
| Issuance of warrants through private placement transaction (Note 3F) | - | - | 68 | - | - | - | 68 | |
| Balance as of June 30, 2024 | 5,478,436 | $5 | $113,903 | $50 | $22 | $(117,269) | $(3,289) | |
| Balance as of April 1, 2024 | 5,351,110 | $5 | $113,050 | $78 | $22 | $(112,780) | $375 | |
| Loss for the period | - | - | - | - | - | (4,489) | (4,489) | |
| Stock-based compensation | - | - | 207 | - | - | - | 207 | |
| Issuance of restricted shares as compensation towards directors | 47,960 | -(*) | 78 | (78) | - | - | - | |
| Issuance of Common Stock upon private placement transaction (Note 3D) | 79,366 | -(*) | 500 | - | - | - | 500 | |
| Restricted shares to be issued as compensation towards directors | - | - | - | 50 | - | - | 50 | |
| Issuance of warrants through private placement transaction (Note 3F) | - | - | 68 | - | - | - | 68 | |
| Balance as of June 30, 2024 | 5,478,436 | $5 | $113,903 | $50 | $22 | $(117,269) | $(3,289) | |
| (*) | Represents amount lower than $1. |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.